Search for a rare disease
Other search option(s)
Stevens-Johnson syndrome
Disease definition
A limited form of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum characterized by destruction and detachment of the skin epithelium, involving less than 10% of the body surface area, and mucous membranes. Onset usually occurs 4-28 days after administration of the causal medication and is most frequently associated with anticonvulsants, antibacterial sulfonamides, allopurinol, nevirapine, and oxicams (non-steroidal anti-inflammatory drugs), but many other medications have also been implicated. The disease is not induced by medication in 15% of cases. Histology is characterized by an epidermal necrolysis. Multiple disabling long-term sequelae (especially cutaneous, ocular and psychological) are frequent.
ORPHA:36426
Classification level: Subtype of disorderA summary on this disease is available in Español (2009) Français (2009) Italiano (2009) Nederlands (2009) Português (2009)
Detailed information
Guidelines
- Emergency guidelines
- Français (2019, pdf) - Orphanet Urgences
- English (2019, pdf) - ERN-Skin
- Clinical practice guidelines
- English (2016) - Br J Dermatol
- Français (2018) - PNDS
- English (2019) - Br J Dermatol
- English (2020) - J Am Acad Dermatol
- English (2020) - Orphanet J Rare Dis
- Français (2021) - PNDS
- English (2021) - Br J Dermatol
- English (2023) - Orphanet J Rare Dis
Disease review articles
- Review article
- Français (2007, pdf) - Rev Praticien
- English (2010) - Orphanet J Rare Dis
produced/endorsed by ERN(s) produced/endorsed by FSMR(s)Additional information